Neoadjuvant PD-1 and LAG-3-targeting bispecific antibody and other immune checkpoint inhibitor combinations in resectable melanoma: the randomized phase 1b/2 Morpheus-Melanoma trial
Nature Medicine, Published online: 24 September 2025; doi:10.1038/s41591-025-03967-2
In the randomized phase 1b/2 Morpheus-Melanoma trial evaluating various neoadjuvant immune checkpoint inhibitor regimens in patients with resectable stage III melanoma, tobemstomig, an anti-PD-1/anti-LAG-3 bispecific antibody, showed the highest pathologic response rate with a better safety profile than the standard treatment approach of ipilimumab plus nivolumab.
Neoadjuvant PD-1 and LAG-3-targeting bispecific antibody and other immune checkpoint inhibitor combinations in resectable melanoma: the randomized phase 1b/2 Morpheus-Melanoma trial
| Divisions of Shy Paris Entertainment | ||||
|---|---|---|---|---|
| Shyparis Entertainment | Shy Paris Bookings | Linkz Radio | Klublinks | Shy Paris |
Shy Paris Bookings is a Division of
❤Shy Paris Entertainment ||||| International Spectacular Events, Stellar Event Planning and Management, & Celebrity Booking Agency. Please contact us as we can provide you with both international and/or local renowned full service event planning and management, & celebrity bookings at shyparisentertainment@gmail.com or
CONTACT: Email: shyparisentertainment@gmail.com
Facebook: ShyParis Youtube: @Shyparis Twitter: @Shyparisent Instagram: shyparisentertainment Whatsapp: 1-437-259-3399
✶✶✶✶✶✶✶✶✶✶✶✶✶✶✶✶✶✶✶✶✶✶✶✶✶✶✶✶✶✶✶✶✶✶✶✶✶✶✶✶✶✶✶✶✶✶✶✶✶✶
SHY PARIS ENTERTAINMENT COMPANIES
✅ ShyParisentertainment.co – https://shyparisentertainment.co
✅ Shyparisbookings.com – https://shyparisbookings.com
✅ Linkzradio.com – https://linkzradio.com
✅ Klublinks.com – https://klublinks.com
✅ Shypariswebdesign.com – https://shypariswebdesign.com
✅ ❤️ Shyparis – htttps://shyparis.com❤️
